Ribonucleotide Reductase Subunit M2 Predicts Survival in Subgroups of Patients with Non-Small Cell Lung Carcinoma: Effects of Gender and Smoking Status-Reference-Cited by-同舟云学术

Ribonucleotide Reductase Subunit M2 Predicts Survival in Subgroups of Patients with Non-Small Cell Lung Carcinoma: Effects of Gender and Smoking Status

Published:2015-05-22 Issue:5 Volume:10 Page:e0127600
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mah Vei,Alavi Mohammad,Márquez-Garbán Diana C.,Maresh Erin L.,Kim Sara R.,Horvath Steve,Bagryanova Lora,Huerta-Yepez Sara,Chia David,Pietras Richard,Goodglick Lee

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. American Cancer Society: Cancer Facts & Figures 2014. Available: http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf.

2. Genomic landscape of non-small cell lung cancer in smokers and never-smokers;R Govindan;Cell,2012

3. Lung cancer in never smokers—a review;S Couraud;Eur J Cancer,2012

4. Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study;H Sakurai;J Thorac Oncol,2010

5. Molecular genetics of lung cancer in people who have never smoked;J Subramanian;Lancet Oncol,2008

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Membrane RRM2-positive cells represent a malignant population with cancer stem cell features in intrahepatic cholangiocarcinoma;Journal of Experimental & Clinical Cancer Research;2024-09-06

2. Reduced ribonucleotide reductase RRM2 subunit expression increases DNA damage and mitochondria dysfunction in woody breast chickens;American Journal of Veterinary Research;2024-02-12

3. Ribonucleotide reductase regulatory subunit M2 (RRM2) as a potential sero-diagnostic biomarker in non-small cell lung cancer;PLOS ONE;2023-09-12

4. MiR-17- 5p/RRM2 regulated gemcitabine resistance in lung cancer A549 cells;Cell Cycle;2023-04-28

5. A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors;PeerJ;2022-11-28